Natalia V. Orlova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natalia V. Orlova has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
- Lydia I. Ilyenko
N. I. Pirogov Russian National Research Medical University (Pirogov University)
14 shared publications - Natalia D. Karseladze
NAKFF Medical Clinic LLC
12 shared publications - Yana G. Spiryakina
N. I. Pirogov Russian National Research Medical University (Pirogov University)
12 shared publications Я. Г. Спирякина
ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н. И. Пирогова» Минздрава России (Пироговский университет)
9 shared publications- S. V. Goryainova.
N. I. Pirogov Russian National Research Medical University (Pirogov University)
8 shared publications - Georgy N. Suvorov
Tyumen State University
7 shared publications
Latest Publications
- Open Access
Three K2-Targeting Sircambvirus Phages: Evidence for Modular Evolution at Genome and Tailspike Levels
Three lytic bacteriophages, Kleo, Medik, and Spark, were isolated on K2-encapsulated Klebsiella pneumoniae and characterized experimentally and by comparative genomics. All three had contractile tails, formed haloed plaques, and were active against both K2 strains tested. On the KL13 isolate M190, Spark exhibited substantially higher plating efficiency (EOP = 1.75 × 10−3), whereas Kleo and Medik showed only low-frequency plaque formation (EOP = 1.76 × 10−8 and 2.78 × 10−8, respectively). They exhibited rapid adsorption-associated declines in recoverable infectious phage titers and reduced preformed biofilm biomass by 59.6–75.8%, whereas survival outcomes in Galleria mellonella varied among phages and doses. Their 46.6–48.0-kb genomes represent candidate members of three distinct species within Sircambvirus. In a 452-genome dataset, gene-sharing relationships extended across whole-genome nucleotide clusters, while major capsid protein and large terminase ATPase-domain phylogenies partitioned the same proteomically coherent group of 54 Jameshumphriesvirinae-associated phages differently. Among the three isolates, whole-genome similarity was greatest between Medik and Spark, whereas the Kleo and Spark tailspike genes shared 99.60% nucleotide identity, compared with a median of 93.23% across the other 48 single-copy homologous genes. Tailspike N-terminal homologs were concentrated in Jameshumphriesvirinae-associated phages, whereas depolymerase-region homologs occurred across several families and tail morphotypes. Together, these patterns provide evidence for modular evolution at both genomic and intragenic levels.
Open AccessThree K2-Targeting Sircambvirus Phages: Evidence for Modular Evolution at Genome and Tailspike Levels
Three lytic bacteriophages, Kleo, Medik, and Spark, were isolated on K2-encapsulated Klebsiella pneumoniae and characterized experimentally and by comparative genomics. All three had contractile tails, formed haloed plaques, and were active against both K2 strains tested. On the KL13 isolate M190, Spark exhibited substantially higher plating efficiency (EOP = 1.75 × 10−3), whereas Kleo and Medik showed only low-frequency plaque formation (EOP = 1.76 × 10−8 and 2.78 × 10−8, respectively). They exhibited rapid adsorption-associated declines in recoverable infectious phage titers and reduced preformed biofilm biomass by 59.6–75.8%, whereas survival outcomes in Galleria mellonella varied among phages and doses. Their 46.6–48.0-kb genomes represent candidate members of three distinct species within Sircambvirus. In a 452-genome dataset, gene-sharing relationships extended across whole-genome nucleotide clusters, while major capsid protein and large terminase ATPase-domain phylogenies partitioned the same proteomically coherent group of 54 Jameshumphriesvirinae-associated phages differently. Among the three isolates, whole-genome similarity was greatest between Medik and Spark, whereas the Kleo and Spark tailspike genes shared 99.60% nucleotide identity, compared with a median of 93.23% across the other 48 single-copy homologous genes. Tailspike N-terminal homologs were concentrated in Jameshumphriesvirinae-associated phages, whereas depolymerase-region homologs occurred across several families and tail morphotypes. Together, these patterns provide evidence for modular evolution at both genomic and intragenic levels.
- Open Access
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 83-87
The biochemistry of aggression and antisocial behavior – the role of the neurotransmitter gamma-aminobutyric acid (GABA)
Aggressive behavior often leads to violent criminal acts. The genetic predisposition to aggressive behavior in some trials was considered as a mitigating circumstance. Aggressive behavior is associated with many genes. Genes encoding gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter, are considered as a candidate gene. Animal studies demonstrate that suppression of gabaergic neurons and a decrease in GABA levels leads to increased aggression. The behavioral effects of alcohol, including aggression, alcohol dependence, and substance use are associated with GABA. The research results presented in the article indicate the role of genes involved in the regulation of GABA, GABRA2, GABRB1, GABRA3, GABRG2, SLC17A7, GAD2 in the tendency to aggressive behavior. Despite the extensive research conducted in the field of genetics and the results demonstrating the association of propensity to aggressive behavior with the carrier of certain genotypes, a combination of genetic data and environmental factors predisposing to antisocial behavior is more often accepted as mitigating circumstances.
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 83-87
Open AccessThe biochemistry of aggression and antisocial behavior – the role of the neurotransmitter gamma-aminobutyric acid (GABA)
Aggressive behavior often leads to violent criminal acts. The genetic predisposition to aggressive behavior in some trials was considered as a mitigating circumstance. Aggressive behavior is associated with many genes. Genes encoding gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter, are considered as a candidate gene. Animal studies demonstrate that suppression of gabaergic neurons and a decrease in GABA levels leads to increased aggression. The behavioral effects of alcohol, including aggression, alcohol dependence, and substance use are associated with GABA. The research results presented in the article indicate the role of genes involved in the regulation of GABA, GABRA2, GABRB1, GABRA3, GABRG2, SLC17A7, GAD2 in the tendency to aggressive behavior. Despite the extensive research conducted in the field of genetics and the results demonstrating the association of propensity to aggressive behavior with the carrier of certain genotypes, a combination of genetic data and environmental factors predisposing to antisocial behavior is more often accepted as mitigating circumstances.
- Open Access
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 68-75
Genetic markers of cardiotoxicity associated with anticancer therapy
The improvement in survival rates for most malignant neoplasms (MNOs) poses a challenge to healthcare in terms of longterm complications of antitumor chemotherapy (ATC). The clinical manifestations of ATC complications affecting various organs are nonspecific, which makes their diagnosis difficult, especially against the background of the course of the underlying MNO. The longterm consequences of ATC administered in childhood may manifest themselves years or even decades later. Doctors across a wide range of specialties need knowledge in the field of pharmacogenetics of chemotherapy drugs, as well as in the clinical manifestations of these drugs, including delayed ones, due to the possibility of adverse effects of chemotherapy on various organs and systems. Due to the use of cardiotoxic drugs in the treatment of malignant neoplasms in childhood, there is a risk of longterm adverse effects on the cardiovascular system.
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 68-75
Open AccessGenetic markers of cardiotoxicity associated with anticancer therapy
The improvement in survival rates for most malignant neoplasms (MNOs) poses a challenge to healthcare in terms of longterm complications of antitumor chemotherapy (ATC). The clinical manifestations of ATC complications affecting various organs are nonspecific, which makes their diagnosis difficult, especially against the background of the course of the underlying MNO. The longterm consequences of ATC administered in childhood may manifest themselves years or even decades later. Doctors across a wide range of specialties need knowledge in the field of pharmacogenetics of chemotherapy drugs, as well as in the clinical manifestations of these drugs, including delayed ones, due to the possibility of adverse effects of chemotherapy on various organs and systems. Due to the use of cardiotoxic drugs in the treatment of malignant neoplasms in childhood, there is a risk of longterm adverse effects on the cardiovascular system.
- Open Access
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 63-67
Clinical effects of hyperbaric oxygenation in the treatment of ischemic heart disease
Hyperbaric oxygenation (HBO) is used in combination therapy for various diseases. HBO increases oxygen delivery to tissues, improves angiogenesis, and prevents thrombus formation. The aim of the study was to investigate the effects of HBO in patients with ischemic heart disease. The study included 40 patients with ischemic heart disease (IHD). The treatment course included standard therapy for ischemic heart disease in accordance with the Clinical Guidelines, as well as HBO using “mild” modes (1.4/55 and 1.5/55 ATA) with the BLKS 303MK device. No adverse events were observed in the patients during the HBO course. During the HBO course, no adverse events were observed in the patients. The use of HBO in treating patients is accompanied by a reduction in inflammatory activity and oxidative stress, normalization of carbohydrate metabolism, and an increase in HDL. The survey results showed a positive effect of HBO on the cognitive functions, psychological status, and physical status of the patients: the proportion of patients with normal cognitive functions increased from 30 % to 97.5 %; the severity of anxiety and depression according to the HADS scale decreased; the frequency of subclinical anxiety and subclinical depression, as well as the intensity of pain, decreased. According to the SF36, physical functioning, overall health status, social functioning, and the physical component of health improved statistically significantly; the total SF36 score increased from 85.2 (77.2–92.4) to 91.5 (84.5–95) points (p<0.001). Tolerance to physical exertion increased: the distance covered in the 6minute walk test increased from 400 (350–400) to 428 (400–450) m (p < 0.001).
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 63-67
Open AccessClinical effects of hyperbaric oxygenation in the treatment of ischemic heart disease
Hyperbaric oxygenation (HBO) is used in combination therapy for various diseases. HBO increases oxygen delivery to tissues, improves angiogenesis, and prevents thrombus formation. The aim of the study was to investigate the effects of HBO in patients with ischemic heart disease. The study included 40 patients with ischemic heart disease (IHD). The treatment course included standard therapy for ischemic heart disease in accordance with the Clinical Guidelines, as well as HBO using “mild” modes (1.4/55 and 1.5/55 ATA) with the BLKS 303MK device. No adverse events were observed in the patients during the HBO course. During the HBO course, no adverse events were observed in the patients. The use of HBO in treating patients is accompanied by a reduction in inflammatory activity and oxidative stress, normalization of carbohydrate metabolism, and an increase in HDL. The survey results showed a positive effect of HBO on the cognitive functions, psychological status, and physical status of the patients: the proportion of patients with normal cognitive functions increased from 30 % to 97.5 %; the severity of anxiety and depression according to the HADS scale decreased; the frequency of subclinical anxiety and subclinical depression, as well as the intensity of pain, decreased. According to the SF36, physical functioning, overall health status, social functioning, and the physical component of health improved statistically significantly; the total SF36 score increased from 85.2 (77.2–92.4) to 91.5 (84.5–95) points (p<0.001). Tolerance to physical exertion increased: the distance covered in the 6minute walk test increased from 400 (350–400) to 428 (400–450) m (p < 0.001).
- Open Access
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 44-51
Genetic assessment of high risk of complications in the maternal–placental–fetal system in hypertensive disorders in pregnant women
Arterial hypertension (AH) is the most common extragenital pathology, which is recorded in every tenth pregnant woman worldwide. In the Russian Federation, the prevalence of AH in pregnant women is even higher, amounting to 7–30 %, and is responsible for 20–25 % of perinatal mortality. Scientific literature has identified more than 1,500 genetic polymorphisms associated with various blood pressure regulation mechanisms. The complex regulation of blood pressure and the multifactorial pathogenesis of hypertension, which are influenced by various genes, suggest that the prognostic significance of genetic analysis may be enhanced by taking into account the combined effect of polymorphisms in different genes. Currently, more than 60 genes have been identified based on the pathophysiology of preeclampsia that may influence the development of preeclampsia. Indications for prescribing a genetic test may include: a history of preeclampsia or cases in close relatives, elevated blood pressure during a previous pregnancy, planning a pregnancy, pregnancy against the background of diabetes, kidney diseases, autoimmune pathologies, excess body weight, as well as a first pregnancy after the age of 40. Thus, genetic assessment of the predisposition to preeclampsia can be a useful tool in medicine for early prediction and prevention of pregnancy complications.
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 44-51
Open AccessGenetic assessment of high risk of complications in the maternal–placental–fetal system in hypertensive disorders in pregnant women
Arterial hypertension (AH) is the most common extragenital pathology, which is recorded in every tenth pregnant woman worldwide. In the Russian Federation, the prevalence of AH in pregnant women is even higher, amounting to 7–30 %, and is responsible for 20–25 % of perinatal mortality. Scientific literature has identified more than 1,500 genetic polymorphisms associated with various blood pressure regulation mechanisms. The complex regulation of blood pressure and the multifactorial pathogenesis of hypertension, which are influenced by various genes, suggest that the prognostic significance of genetic analysis may be enhanced by taking into account the combined effect of polymorphisms in different genes. Currently, more than 60 genes have been identified based on the pathophysiology of preeclampsia that may influence the development of preeclampsia. Indications for prescribing a genetic test may include: a history of preeclampsia or cases in close relatives, elevated blood pressure during a previous pregnancy, planning a pregnancy, pregnancy against the background of diabetes, kidney diseases, autoimmune pathologies, excess body weight, as well as a first pregnancy after the age of 40. Thus, genetic assessment of the predisposition to preeclampsia can be a useful tool in medicine for early prediction and prevention of pregnancy complications.
- Open Access
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 14-22
The role of vitamins and min erals in pediatric practice
In childhood, due to an accelerated metabolism, the need for vitamins and microelements increases. Nutritional deficiency of micronutrients not only increases the risk of diseases but also leads to delays in the physical and mental development of children. The clinical manifestations of nutrient deficiency described in the article are nonspecific, and in some cases may not manifest themselves for a long time, which makes timely diagnosis and correction difficult. Among the causes leading to nutrient deficiency, the leading one is an unbalanced diet with a reduced content of vitamins and minerals. In children and adolescents, along with the physiological increased need for vitamins and minerals, there are risks of deficiency due to selective food choices, adherence to trendy diets, and, in some cases, the presence of chronic diseases and the use of medications that affect the absorption of micronutrients. The diet of most preschoolage children in the Russian Federation is characterized by multiple micronutrient deficiencies. The widespread prevalence of vitamin and mineral deficiencies and insufficiencies necessitates their supplementation in the form of vitamin and mineral complexes. The essential components of vitamin and mineral supplements for children are vitamin D, Bgroup vitamins, calcium, magnesium, zinc, and iodine. Adding microelements and vitamins to the diet can help reduce the risks associated with low intake of micronutrients. The choice of a vitamin and mineral supplement for children should be based on the list of substances included in the supplement, its effectiveness, and safety; the doses of vitamins and minerals should correspond to the child’s age-related needs.
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 14-22
Open AccessThe role of vitamins and min erals in pediatric practice
In childhood, due to an accelerated metabolism, the need for vitamins and microelements increases. Nutritional deficiency of micronutrients not only increases the risk of diseases but also leads to delays in the physical and mental development of children. The clinical manifestations of nutrient deficiency described in the article are nonspecific, and in some cases may not manifest themselves for a long time, which makes timely diagnosis and correction difficult. Among the causes leading to nutrient deficiency, the leading one is an unbalanced diet with a reduced content of vitamins and minerals. In children and adolescents, along with the physiological increased need for vitamins and minerals, there are risks of deficiency due to selective food choices, adherence to trendy diets, and, in some cases, the presence of chronic diseases and the use of medications that affect the absorption of micronutrients. The diet of most preschoolage children in the Russian Federation is characterized by multiple micronutrient deficiencies. The widespread prevalence of vitamin and mineral deficiencies and insufficiencies necessitates their supplementation in the form of vitamin and mineral complexes. The essential components of vitamin and mineral supplements for children are vitamin D, Bgroup vitamins, calcium, magnesium, zinc, and iodine. Adding microelements and vitamins to the diet can help reduce the risks associated with low intake of micronutrients. The choice of a vitamin and mineral supplement for children should be based on the list of substances included in the supplement, its effectiveness, and safety; the doses of vitamins and minerals should correspond to the child’s age-related needs.
- Open Access
- 13 May 2026
- Published by Alfmed LLC in Medical alphabet
- No. 2,p. 32-36
The role of dopaminergic system genes in aggression and antisocial behavior
The determinants of aggressive human behavior and criminal aggression include genetic factors and environmental influences. Experiments have shown that the manifestation of aggressive behavior largely depends on the level of dopamine. The results of studies of the genes of five dopamine receptors DRD1–DRD4, the catechol-O-methyltransferase gene, the monoamine oxidase-A gene, and genes encoding enzymes involved in the synthesis or degradation of dopamine are presented. The results of most studies confirm the relationship of dopaminergic receptor genes with aggression, antisocial behavior, impulsivity. At the same time, a number of studies have not revealed the relationship of genes regulating the function of dopamine with antisocial behavior. The inconsistency of research results on genetic predisposition to antisocial behavior may be associated with a number of methodological problems and errors.
- 13 May 2026
- Published by Alfmed LLC in Medical alphabet
- No. 2,p. 32-36
Open AccessThe role of dopaminergic system genes in aggression and antisocial behavior
The determinants of aggressive human behavior and criminal aggression include genetic factors and environmental influences. Experiments have shown that the manifestation of aggressive behavior largely depends on the level of dopamine. The results of studies of the genes of five dopamine receptors DRD1–DRD4, the catechol-O-methyltransferase gene, the monoamine oxidase-A gene, and genes encoding enzymes involved in the synthesis or degradation of dopamine are presented. The results of most studies confirm the relationship of dopaminergic receptor genes with aggression, antisocial behavior, impulsivity. At the same time, a number of studies have not revealed the relationship of genes regulating the function of dopamine with antisocial behavior. The inconsistency of research results on genetic predisposition to antisocial behavior may be associated with a number of methodological problems and errors.
- Open Access
- 20 March 2026
- Published by Alfmed LLC in Medical alphabet
- No. 4,p. 46-49
The relationship between monoamine oxidase deficiency and inheritance of aggressive behavior
Impulsive aggression is a widespread behavior problem. The article presents the results of studying the relationship of pathologically aggressive behavior with hereditary factors. The tendency to aggressive behavior is interrelated with serotonin metabolism, which is regulated by the monoamine oxidase (MAO) gene. The research results indicate that aggressive behavior is correlated with the number of tandem repeats of the monoamine oxidase А (MAOA) gene. Reactive aggression is promoted by low-functional variants of alleles. The tendency to aggression is influenced by the presence of abuse, neglect, or traumatic life events in childhood. Alleles of the MAOA gene are associated not only with impulsive aggression in an individual, but also with the influence of the environment on the formation of aggressive criminal behavior. Examples are given when a genetic predisposition to criminal behavior served as an argument in favor of a reduced sentence. Behavioral genetics research requires more serious requirements for research design and methodology in order to obtain reliable and reliable results.
- 20 March 2026
- Published by Alfmed LLC in Medical alphabet
- No. 4,p. 46-49
Open AccessThe relationship between monoamine oxidase deficiency and inheritance of aggressive behavior
Impulsive aggression is a widespread behavior problem. The article presents the results of studying the relationship of pathologically aggressive behavior with hereditary factors. The tendency to aggressive behavior is interrelated with serotonin metabolism, which is regulated by the monoamine oxidase (MAO) gene. The research results indicate that aggressive behavior is correlated with the number of tandem repeats of the monoamine oxidase А (MAOA) gene. Reactive aggression is promoted by low-functional variants of alleles. The tendency to aggression is influenced by the presence of abuse, neglect, or traumatic life events in childhood. Alleles of the MAOA gene are associated not only with impulsive aggression in an individual, but also with the influence of the environment on the formation of aggressive criminal behavior. Examples are given when a genetic predisposition to criminal behavior served as an argument in favor of a reduced sentence. Behavioral genetics research requires more serious requirements for research design and methodology in order to obtain reliable and reliable results.
- Open Access
- 20 March 2026
- Published by Alfmed LLC in Medical alphabet
- No. 4,p. 29-33
The role of gene polymorphisms associated with the functioning of the renin-angiotensin system in the development of arterial hypertension and preeclampsia
Hereditary predisposition is one of the risk factors for arterial hypertension. The renin-angiotensin-aldosterone system plays a key role in the pathogenesis of arterial hypertension. Previous studies have shown a correlation between the AGT and AGTR genes and the risk of developing arterial hypertension. The genes of the renin-angiotensin system are considered candidates for predisposition to preeclampsia. In our study, we examined the relationship between arterial hypertension (AH) and polymorphisms of the renin-angiotensin-aldosterone system genes: AGT: 704 T>C, AGT: 521 C>T, AGTR 1: 1166 A>C, and AGTR 2: 1675 G>A, among the European population of Moscow. The presence of the T allele of the AGT gene (T704C) has a protective effect on the development of AH. The CT and TT genotypes of the AGT gene (C 521T) are significantly more common in hypertensive patients, which may indicate a negative effect of the T allele on the development of hypertension. Carrying the CC genotype of the AGTR 1 gene (A1166C) may predispose to hypertension. It has been established that the presence of the G allele and the G allele.
- 20 March 2026
- Published by Alfmed LLC in Medical alphabet
- No. 4,p. 29-33
Open AccessThe role of gene polymorphisms associated with the functioning of the renin-angiotensin system in the development of arterial hypertension and preeclampsia
Hereditary predisposition is one of the risk factors for arterial hypertension. The renin-angiotensin-aldosterone system plays a key role in the pathogenesis of arterial hypertension. Previous studies have shown a correlation between the AGT and AGTR genes and the risk of developing arterial hypertension. The genes of the renin-angiotensin system are considered candidates for predisposition to preeclampsia. In our study, we examined the relationship between arterial hypertension (AH) and polymorphisms of the renin-angiotensin-aldosterone system genes: AGT: 704 T>C, AGT: 521 C>T, AGTR 1: 1166 A>C, and AGTR 2: 1675 G>A, among the European population of Moscow. The presence of the T allele of the AGT gene (T704C) has a protective effect on the development of AH. The CT and TT genotypes of the AGT gene (C 521T) are significantly more common in hypertensive patients, which may indicate a negative effect of the T allele on the development of hypertension. Carrying the CC genotype of the AGTR 1 gene (A1166C) may predispose to hypertension. It has been established that the presence of the G allele and the G allele.
- 12 December 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 20,p. 166-173
An integrated approach to the treatment of acute productive cough
Acute cough is most often a benign self-resolving condition. The main causes of acute productive cough include acute bronchitis, community-acquired pneumonia, exacerbation of chronic obstructive pulmonary disease (COPD), and exacerbation of bronchial asthma. Acute bronchitis is most often caused by a viral and viral-bacterial infection, and is an exceptional diagnosis that requires laboratory examination, radiography, and spirometry. For the assessment of both chronic and acute cough, the following tools can be used: Visual Analog Scale for cough severity (VAS), Cough Symptoms Score (CSS), Cough Severity Diary (CSD), Leicester Cough Questionnaire (LCQ), Cough Specific Quality of Life Questionnaire (CQLQ), Cough Severity Diary (CSD), Cough and Sputum Assessment Questionnaire (CASA-Q), and the Breathlessness, Cough, and Sputum Scale (BCSS). Using the example of a clinical case, the article discusses an algorithm for diagnosing acute bronchitis and its treatment in accordance with modern recommendations. Coughing causes a number of complications, including a negative impact on the quality of life. Mucoactive drugs are used to treat productive cough, which are classified according to the mechanism of their action and the integration of mucus. They are grouped into four different classes: expectorants, mucokinetics, mucoregulators, and mucolytics. Additionally, bronchodilators are used for airway obstruction. In most cases, combined mucoactive drugs are effective. Antitussive drugs based on medicinal plants are low-toxic and effective cough treatments. Using the example of a clinical case, the effectiveness of the herbal medicinal product Bronchipret® has been demonstrated. The results of clinical studies confirming the efficacy and safety of the use of two dosage forms of Bronchipret® (syrup, tablets) in adults and children are presented.
- 12 December 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 20,p. 166-173
An integrated approach to the treatment of acute productive cough
Acute cough is most often a benign self-resolving condition. The main causes of acute productive cough include acute bronchitis, community-acquired pneumonia, exacerbation of chronic obstructive pulmonary disease (COPD), and exacerbation of bronchial asthma. Acute bronchitis is most often caused by a viral and viral-bacterial infection, and is an exceptional diagnosis that requires laboratory examination, radiography, and spirometry. For the assessment of both chronic and acute cough, the following tools can be used: Visual Analog Scale for cough severity (VAS), Cough Symptoms Score (CSS), Cough Severity Diary (CSD), Leicester Cough Questionnaire (LCQ), Cough Specific Quality of Life Questionnaire (CQLQ), Cough Severity Diary (CSD), Cough and Sputum Assessment Questionnaire (CASA-Q), and the Breathlessness, Cough, and Sputum Scale (BCSS). Using the example of a clinical case, the article discusses an algorithm for diagnosing acute bronchitis and its treatment in accordance with modern recommendations. Coughing causes a number of complications, including a negative impact on the quality of life. Mucoactive drugs are used to treat productive cough, which are classified according to the mechanism of their action and the integration of mucus. They are grouped into four different classes: expectorants, mucokinetics, mucoregulators, and mucolytics. Additionally, bronchodilators are used for airway obstruction. In most cases, combined mucoactive drugs are effective. Antitussive drugs based on medicinal plants are low-toxic and effective cough treatments. Using the example of a clinical case, the effectiveness of the herbal medicinal product Bronchipret® has been demonstrated. The results of clinical studies confirming the efficacy and safety of the use of two dosage forms of Bronchipret® (syrup, tablets) in adults and children are presented.